; or (B) to increase the knowledge and awareness of health care providers and health care leaders about the potential risks and benefits of human cell and tissue products transplants, including the risks that such transplants may lead to infectious diseases, including tuberculosis, latent tuberculosis infection, and sepsis. (d) Media campaigns (1) In general In carrying out the education campaign under subsection (a), the Secretary, after taking into consideration the advice of stakeholder experts, may award grants to, or enter into contracts with, entities to establish national multimedia campaigns to increase public and health care provider awareness regarding the potential risks of human cell and tissue products transplants. (2) Inclusions The multimedia campaigns under paragraph (1) may include advertising through television, radio, print media, billboards, posters, all forms of existing and emerging social networking media, other internet media, and any other medium determined appropriate by the Secretary. 4. Civil penalties for violation of requirements for human cell and tissue products (a) In general Any person who violates a requirement of section 361 of the Public Health Service Act ( 42 U.S.C. 264 ) or part 1271 of title 21, Code of Federal Regulations (or successor regulations) with respect to human cell or tissue products shall be liable to the United States for a civil penalty in an amount not to exceed the sum of— (1) (A) $20,000 for each violation; or (B) $20,000 for each day of a continuing violation